LCM
NKTR icon

Landscape Capital Management’s Nektar Therapeutics NKTR Stock Holding History

Landscape Capital Management’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.66M Sell
36,907
-23,524
-39% -$1.34M 0.17% 188
2025
Q4 		$2.56M Buy
+60,431
New +$3.38M 0.17% 183
2023
Q1 		– Sell
-1,628
Closed -$55.2K – 740
2022
Q4 		$55.2K Hold
1,628
– – 0.01% 782
2022
Q3 		$78K Sell
1,628
-199
-11% -$11.8K 0.01% 912
2022
Q2 		$104K Buy
1,827
+900
+97% +$56.8K 0.01% 876
2022
Q1 		$75K Buy
+927
New +$137K 0.01% 899
2019
Q4 		– Sell
-2,291
Closed -$626K – 770
2019
Q3 		$626K Buy
2,291
+969
+73% +$355K 0.05% 353
2019
Q2 		$706K Hold
1,322
– – 0.06% 342
2019
Q1 		$666K Sell
1,322
-70
-5% -$41.5K 0.06% 345
2018
Q4 		$686K Buy
+1,392
New +$840K 0.06% 364
2017
Q2 		– Sell
-1,039
Closed -$191K – 408
2017
Q1 		$191K Hold
1,039
– – 0.02% 450
2016
Q4 		$191K Buy
+1,039
New +$211K 0.03% 480

Other funds holding NKTR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Landscape Capital Management's NKTR Position: Q1 2026 in Review

Landscape Capital Management reduced its Nektar Therapeutics (NKTR) stake by 39% in Q1 2026, selling an estimated $1.34M and leaving 36,907 shares worth $2.66M. The position accounts for 0.17% of the portfolio, ranked #188.

Landscape Capital Management first reported a position in NKTR in Q4 2016 and has held it in 12 quarters since. 215 funds tracked by Wall St. Rank hold NKTR as of Q1 2026.

  • Landscape Capital Management held 36,907 shares of Nektar Therapeutics worth $2.66M as of Q1 2026.
  • Landscape Capital Management sold 23,524 Nektar Therapeutics shares in Q1 2026, an estimated $1.34M.
  • Nektar Therapeutics made up 0.17% of Landscape Capital Management's portfolio in Q1 2026, its #188 holding.
  • Landscape Capital Management first reported a position in Nektar Therapeutics in Q4 2016 and has held it in 12 quarters since.
  • 215 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q1 2026.

Based on Landscape Capital Management's 13F filing for Q1 2026, filed 12 May 2026.